News | May 13, 2025
Morepen Laboratories reports Q4 FY25 consolidated PAT at Rs. 20.31 Cr
The company has posted net profit of Rs. 118.01 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 118.01 crores for the Financial Year ended March 31, 2025
ISPP will analyze health systems across states, identifying scalable models and actionable insights to strengthen India's healthcare delivery
30th Lab in Thyrocare’s expanding network to bring advanced, affordable diagnostics in Bihar and beyond
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
The FDA issued Form 483 with one observation related to building and facility management
Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
The Subsidiary has received one inspectional observation in Form 483
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
Subscribe To Our Newsletter & Stay Updated
